HCW Biologics is trading 6.8% up at $2.76 as the stock bounces back from several sharp moves over the past week.
- The move appears driven by thin trading and prior volatility, with no new company-specific headlines, earnings, or analyst calls reported since the prior close.
- Broader market activity remains influenced by general risk sentiment as investors remain cautious ahead of the Fed’s FOMC statement.